Eminence Capital’s Charles River Laboratories CRL Stock Holding History

Eminence Capital’s Portfolio CRL Stock Details CRL Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell
2025 Q1	$65.5M	Sell
2024 Q4	$116M	Sell
2024 Q3	$198M	Buy
2021 Q1	–	Sell
2020 Q4	$17M	Buy
2020 Q3	–	Sell
2020 Q2	$22.1M	Buy